Jean Hoffman is a member of the board of MedRhythms, The Jackson Laboratory, Argenta and the Casco Bay Lines Island Transit District. She previously founded and led two companies from inception to sale to public companies. Putney, the most recent company Jean built, was sold to Dechra Holdings US Inc., a subsidiary of Dechra Pharmaceuticals PLC (LSE: DPH) for $200 million in April 2016.
Jean founded, chaired the Board of Directors and led Putney as President and CEO from inception to exit, generating a 4X cash on cash return for Putney’s institutional investors. Ms. Hoffman developed the strategy, raised over $60 million in debt and equity and recruited the outstanding team that built Putney into America’s leading generic drug company for pets.